Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AXERT 6.25MG DIN 02248128

Status: Cancelled Post Market
Holder: MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Molecule: ALMOTRIPTAN (ALMOTRIPTAN MALATE)

Health Canada record

Active ingredient(s)ALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN02CC05 ALMOTRIPTAN
Original market date08-Dec-2003
Current status date27-Oct-2017
SourceHealth Canada DPD

Establishment licence of the holder

McNeil Consumer & Specialty Pharmaceuticals — licence , not currently licensed, last inspection rating C (2018-06-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing ALMOTRIPTAN (ALMOTRIPTAN MALATE)

DINProductCompanyFormStrengthStatus
02570297AG-ALMOTRIPTANANGITA PHARMA INC.TabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGApproved
02570289AG-ALMOTRIPTANANGITA PHARMA INC.TabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MGApproved
02466821ALMOTRIPTANSANIS HEALTH INCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGMarketed
02424029ALMOTRIPTANPRO DOC LIMITEETabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGMarketed
02556022JAMP ALMOTRIPTANJAMP PHARMA CORPORATIONTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MGApproved
02556030JAMP ALMOTRIPTANJAMP PHARMA CORPORATIONTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGApproved
02398443MYLAN-ALMOTRIPTANMYLAN PHARMACEUTICALS ULCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGMarketed
02398435MYLAN-ALMOTRIPTANMYLAN PHARMACEUTICALS ULCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MGMarketed
02405334SANDOZ ALMOTRIPTANSANDOZ CANADA INCORPORATEDTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGMarketed
02434849TEVA-ALMOTRIPTANTEVA CANADA LIMITEDTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGMarketed
02405806APO-ALMOTRIPTANAPOTEX INCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGDormant
02405792APO-ALMOTRIPTANAPOTEX INCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 6.25 MGDormant
02248129AXERT 12.5MGMCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGCancelled Post Market
02441411PMS-ALMOTRIPTANPHARMASCIENCE INCTabletALMOTRIPTAN (ALMOTRIPTAN MALATE) 12.5 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
83932006-11-07New Drug Submission (NDS)MANUFACTURER NAME CHANGE
262003-09-29New Drug Submission (NDS)
Request a quote for AXERT 6.25MG

How to read a Canadian DIN record